TY - JOUR
T1 - Microvascular and Systemic Impact of Resuscitation with PEGylated Carboxyhemoglobin-Based Oxygen Carrier or Hetastarch in a Rat Model of Transient Hemorrhagic Shock
AU - Nugent, William H.
AU - Sheppard, Forest R.
AU - Dubick, Michael A.
AU - Cestero, Ramon F.
AU - Darlington, Daniel N.
AU - Jubin, Ronald
AU - Abuchowski, Abe
AU - Song, Bjorn K.
N1 - Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background:Hemorrhage is the leading cause of preventable, traumatic death. Currently, prehospital resuscitation fluids provide preload but not oxygen-carrying capacity - a critical blood function that mitigates microvascular ischemia and tissue hypoxia during hemorrhagic shock. Solutions containing polymerized hemoglobin have been associated with vasoactive and hypertensive events. A novel hemoglobin-based oxygen carrier, modified with PEGylation and CO moieties (PEG-COHb), may overcome these limitations.Objectives:To evaluate the systemic and microcirculatory effects of PEG-COHb as compared with the 6% hetastarch in a rat model of hemorrhagic shock.Methods:Male Sprague Dawley rats (N=20) were subjected to severe, controlled, hemorrhagic shock. Animals were randomized to 20% estimated blood-volume resuscitation with either 6% hetastarch or PEG-COHb. Continuous, invasive, cardiovascular measurements, and arterial blood gases were measured. Microcirculatory measurements of interstitial oxygenation (PISFO2) and vasoactivity helped model oxygen delivery in the spinotrapezius muscle using intravital and phosphorescence quenching microscopy.Results:Hemorrhage reduced mean arterial pressure (MAP), arteriolar diameter, and PISFO2, and increased lactate 10-fold in both groups. Resuscitation with both PEG-COHb and hetastarch improved cardiovascular parameters. However, PEG-COHb treatment resulted in higher MAP (P<0.001), improved PISFO2(14 [PEG-COHb] vs. 5 [hetastarch] mmHg; P<0.0001), lower lactate post-resuscitation (P<0.01), and extended survival from 90 to 142 min (P<0.001) as compared with the hetastarch group.Conclusions:PEG-COHb improved MAP PISFO2, lactate, and survival time as compared with 6% hetastarch resuscitation. Importantly, hypertension and vasoactivity were not detected in response to PEG-COHb resuscitation supporting further investigation of this resuscitation strategy.
AB - Background:Hemorrhage is the leading cause of preventable, traumatic death. Currently, prehospital resuscitation fluids provide preload but not oxygen-carrying capacity - a critical blood function that mitigates microvascular ischemia and tissue hypoxia during hemorrhagic shock. Solutions containing polymerized hemoglobin have been associated with vasoactive and hypertensive events. A novel hemoglobin-based oxygen carrier, modified with PEGylation and CO moieties (PEG-COHb), may overcome these limitations.Objectives:To evaluate the systemic and microcirculatory effects of PEG-COHb as compared with the 6% hetastarch in a rat model of hemorrhagic shock.Methods:Male Sprague Dawley rats (N=20) were subjected to severe, controlled, hemorrhagic shock. Animals were randomized to 20% estimated blood-volume resuscitation with either 6% hetastarch or PEG-COHb. Continuous, invasive, cardiovascular measurements, and arterial blood gases were measured. Microcirculatory measurements of interstitial oxygenation (PISFO2) and vasoactivity helped model oxygen delivery in the spinotrapezius muscle using intravital and phosphorescence quenching microscopy.Results:Hemorrhage reduced mean arterial pressure (MAP), arteriolar diameter, and PISFO2, and increased lactate 10-fold in both groups. Resuscitation with both PEG-COHb and hetastarch improved cardiovascular parameters. However, PEG-COHb treatment resulted in higher MAP (P<0.001), improved PISFO2(14 [PEG-COHb] vs. 5 [hetastarch] mmHg; P<0.0001), lower lactate post-resuscitation (P<0.01), and extended survival from 90 to 142 min (P<0.001) as compared with the hetastarch group.Conclusions:PEG-COHb improved MAP PISFO2, lactate, and survival time as compared with 6% hetastarch resuscitation. Importantly, hypertension and vasoactivity were not detected in response to PEG-COHb resuscitation supporting further investigation of this resuscitation strategy.
KW - Carboxyhemoglobin
KW - hemoglobin-based oxygen carrier
KW - hemorrhagic shock
KW - interstitial oxygenation
KW - microcirculation
KW - phosphorescence quenching microscopy
KW - resuscitation
KW - trauma
UR - http://www.scopus.com/inward/record.url?scp=85081940026&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081940026&partnerID=8YFLogxK
U2 - 10.1097/SHK.0000000000001370
DO - 10.1097/SHK.0000000000001370
M3 - Article
C2 - 31045989
AN - SCOPUS:85081940026
SN - 1073-2322
VL - 53
SP - 493
EP - 502
JO - Shock
JF - Shock
IS - 4
ER -